NCT02128321
- Conditions
- Healthy Subjects, Pharmacokinetics of Caffeine, Pharmacokinetics of Repaglinide
- Locations
-
- Parexel Early Phase Clinical Unit Baltimore, Maryland, United States
Clinical trial condition
Explore clinical trials studying Pharmacokinetics of Repaglinide. Study availability and eligibility vary by location and protocol.
NCT02128321